best stock february 2017 to september 2017

GT Biopharma (GTBP) had the highest return between February 1, 2017 and September 30, 2017 by a US stock, returning 12,550%.

ASSET DATE % RETURN
GT Biopharma (GTBP)
2/1/2017 - 9/30/2017
12,550%
FingerMotion (FNGR)
2/1/2017 - 9/30/2017
9,100%
HIVE Blockchain Technologies (HIVE)
2/1/2017 - 9/30/2017
2,144.35%
Freedom (FRHC)
2/1/2017 - 9/30/2017
1,500%
GrabAGun Digital (PEW)
2/1/2017 - 9/30/2017
1,189.71%
Datasea (DTSS)
2/1/2017 - 9/30/2017
1,100%
Ocean Power Technologies (OPTT)
2/1/2017 - 9/30/2017
836.33%
NioCorp Developments Ltd Common Stock (NB)
2/1/2017 - 9/30/2017
760%
Zynex (ZYXI)
2/1/2017 - 9/30/2017
512.61%
Nutex Health (NUTX)
2/1/2017 - 9/30/2017
450%
Dynavax Technologies (DVAX)
2/1/2017 - 9/30/2017
424.39%
Fennec Pharmaceuticals (FENC)
2/1/2017 - 9/30/2017
415.81%
Renovaro Biosciences (RENB)
2/1/2017 - 9/30/2017
400%
XOMA (XOMA)
2/1/2017 - 9/30/2017
336.67%
Processa Pharmaceuticals (PCSA)
2/1/2017 - 9/30/2017
328.57%
TSS, Inc Common Stock (TSSI)
2/1/2017 - 9/30/2017
327.99%
Sangamo Therapeutics (SGMO)
2/1/2017 - 9/30/2017
322.54%
Esperion Therapeutics (ESPR)
2/1/2017 - 9/30/2017
309.48%
Netcapital (NCPL)
2/1/2017 - 9/30/2017
300%
Portage Biotech (PRTG)
2/1/2017 - 9/30/2017
274.55%
AlphaTON Capital (ATON)
2/1/2017 - 9/30/2017
274.55%
Abeona Therapeutics (ABEO)
2/1/2017 - 9/30/2017
270.65%
Verastem (VSTM)
2/1/2017 - 9/30/2017
270.08%
Puma Biotechnology (PBYI)
2/1/2017 - 9/30/2017
266.77%
WW International, Inc Common Stock (WW)
2/1/2017 - 9/30/2017
249.8%